The Role of Inhaled Corticosteroids in Reducing Cardiovascular Risk: Seeing Is Not Always Believing

Affiliations

Editorial

Jennifer K Quint. Am J Respir Crit Care Med. 2025 Feb.

. 2025 Feb;211(2):142-143.

doi: 10.1164/rccm.202407-1494ED.

No abstract available

Comment on

Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).
Singh D, Martinez FJ, Hurst JR, Han MK, Gale CP, Fredriksson M, Kisielewicz D, Mushunje A, Movitz C, Ojili N, Parikh H, Arya N, Bowen K, Patel M. Singh D, et al. Am J Respir Crit Care Med. 2025 Feb;211(2):205-214. doi: 10.1164/rccm.202312-2311OC. Am J Respir Crit Care Med. 2025. PMID: 39213002 Clinical Trial.

1. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis . 2018;12:1753465817750524. - PMC - PubMed
1. Graul EL, Nordon C, Rhodes K, Marshall J, Menon S, Kallis C, et al. Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study. Am J Respir Crit Care Med . 2024;209:960–972. - PMC - PubMed
1. Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD . 2010;7:375–382. - PMC - PubMed
1. Whittaker H, Rothnie KJ, Quint JK. Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax . 2024;79:202–208. - PubMed
1. Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax . 2021;76:807–814. - PMC - PubMed